Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
171.31B
Market cap171.31B
Price-Earnings ratio
9.62
Price-Earnings ratio9.62
Dividend yield
3.12%
Dividend yield3.12%
Average volume
15.07M
Average volume15.07M
High today
$39.32
High today$39.32
Low today
$38.16
Low today$38.16
Open price
$38.90
Open price$38.90
Volume
18.38M
Volume18.38M
52 Week high
$64.16
52 Week high$64.16
52 Week low
$35.12
52 Week low$35.12

NVO News

Simply Wall St 12h
Novo Nordisk Stock Still Looks Cheap On Earnings Today

has seen its share price retreat sharply in recent years, which puts fresh focus on whether today's valuation is still supported by its earnings power. With the...

Novo Nordisk Stock Still Looks Cheap On Earnings Today
Nasdaq 1d
Novo Nordisk Has a Fresh New Name -- but It Still Faces the Same Old Problems

Key Points Novo Nordisk is in the middle of an important product launch, as it rolls out a pill version of its GLP-1 drug. The company hopes to regain lost ma...

Novo Nordisk Has a Fresh New Name -- but It Still Faces the Same Old Problems
Barron's 1d
Beyond Eli Lilly and Novo Nordisk: Rising Obesity Drug Stocks to Watch

You are now leaving Barron's website By clicking on the “Proceed” button below, you will be redirected to a third-party website owned and operated by Hong Kong...

Beyond Eli Lilly and Novo Nordisk: Rising Obesity Drug Stocks to Watch

More NVO News

TipRanks 1d
Novo Nordisk price target lowered to DKK 245 from DKK 265 at Deutsche Bank

Deutsche Bank lowered the firm’s price target on Novo Nordisk (NVO) to DKK 245 from DKK 265 and keeps a Sell rating on the shares. Published first on TheFly –...

Nasdaq 1d
Novo's CEO Called Ozempic's Patent Cliff the "Elephant in the Room" Yesterday. Is the Stock Still a Buy?

Key Points The molecule, the active ingredient in both Wegovy and Ozempic, powered the company to unprecedented success. With that, however, investor expectat...

Novo's CEO Called Ozempic's Patent Cliff the "Elephant in the Room" Yesterday. Is the Stock Still a Buy?
TipRanks 2d
Novo CEO says company needs to increase investor confidence, Bloomberg says

Novo Nordisk (NVO) CEO Mike Doustdar said the company has to do more to increase investor confidence as it faces patent expiration in the U.S. and Europe for Oz...

TipRanks 2d
Novo Stock: Deutsche Bank Keeps Sell Rating, Says Growth Strategy ‘Underwhelming on Multiple Fronts’

Shares in Danish pharma giant Novo (NVO) fell by 7.96% to $39.80 on Monday. This came after its new growth strategy, revealed at its biennial Capital Markets Da...

Simply Wall St 2d
Novo Nordisk And 2 Other Top Dividend Stocks

With a senior Federal Reserve official warning that the fight against inflation may be painful and involve higher interest rates, dependable cash payouts sudden...

Novo Nordisk And 2 Other Top Dividend Stocks
TipRanks 2d
Eli Lilly Stock Rises After Company Provides Update on Obesity Pill Sales

Eli Lilly’s (LLY) stock is up about 2% on the afternoon of Sept. 21 after the company provided an update on sales of its weight-loss pill called “Foundayo.” In...

Nasdaq 2d
Why Novo Nordisk Stock Just Crashed

Key Points Novo Nordisk just admitted that its CagriSema weight loss drug isn't obviously better than Zepbound. This is a win for Eli Lilly, and a loss for No...

Why Novo Nordisk Stock Just Crashed

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.